Antibody-rich plasma treatment reduced deaths for COVID-19 patients: Mayo Clinic study

Blood plasma transfusions with high concentrations of COVID-19 antibodies reduced deaths among some virus patients, according to a new study conducted by Mayo Clinic researchers, lending credibility to one of the few known treatments for the illness. “Early administration of high-titer convalescent plasma against SARS-CoV-2 to mildly ill infected older adults reduced the progression of…
News | New York Post

EMPLOYMENT SEARCH UPDATE: